Structured Summary
Abstract
Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilized fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
Synonyms
1 entry terms
- Fibrinogens, Abnormal
MeSH Record
Aspects Covered
29 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
89
MeSH Record
Previous Indexing
- Fibrinogen (1966-1988)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Abnormal Fibrinogens. Medical Subject Headings (MeSH). 2026. Unique ID D015241. http://id.nlm.nih.gov/mesh/2026/D015241
- Abnormal Fibrinogens. In: Wikidata. https://www.wikidata.org/wiki/Q76524549